GH Research (GHRS) Change in Acquisitions & Divestments (2024 - 2026)
GH Research (GHRS) posted quarterly Change in Acquisitions & Divestments of -$72000.0 for Q4 2025, up 99.62% year-over-year from -$36068.3 in Q4 2024, and down 118.18% quarter-over-quarter from -$33000.0 in Q3 2025.
Analysis
GH Research (GHRS) Change in Acquisitions & Divestments (2024 - 2026) Analysis & Trends
GH Research's Change in Acquisitions & Divestments history runs 4 years deep, the most recent figure standing at -$72000.0 for Q4 2025.
- In Q4 2025, Change in Acquisitions & Divestments rose 99.62% year-over-year to -$72000.0; the TTM figure through Dec 2025 stood at $4.7 million (up 132.33% YoY), while the FY2025 annual figure was $26.7 million, down 1.75% from the prior year.
- Change in Acquisitions & Divestments for Q4 2025 stood at -$72000.0, down from -$33000.0 in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $53.9 million in Q4 2023, with the low at -$54.0 million in Q1 2023.
- The 4-year median for Change in Acquisitions & Divestments is -$72000.0 (2025), against an average of -$863230.8.
- The sharpest annual moves came in 2023 and 2024: Change in Acquisitions & Divestments soared 9560.39% in 2023, then slumped 135.25% in 2024.
- GH Research's Change in Acquisitions & Divestments stood at $558000.0 in 2022, then jumped by 9560.39% to $53.9 million in 2023, then plunged by 135.25% to -$19.0 million in 2024, then jumped by 99.62% to -$72000.0 in 2025.
- Business Quant data shows GHRS's Change in Acquisitions & Divestments at -$72000.0 in Q4 2025, -$33000.0 in Q3 2025, and -$82000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | GH Research | 1.72 Bn | 1.36 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.36 Mn |
| Mar 31, 2026 | 8.70 Mn |
| Dec 31, 2025 | 8.86 Mn |
| Sep 30, 2025 | 9.82 Mn |
| Jun 30, 2025 | 3.18 Mn |
| Mar 31, 2025 | 4.84 Mn |
| Dec 31, 2024 | 8.36 Mn |
| Sep 30, 2024 | 5.29 Mn |
| Jun 30, 2024 | 9.74 Mn |
| Mar 31, 2024 | 3.80 Mn |